OOIR: Observatory of International Research

Papers

(The median citation count of Antiviral Therapy is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective	56
Treatment-related early discontinuations and adverse events among newly diagnosed people living with HIV initiating integrase inhibitors in a real-world setting	25
Retrospective chart review of transplant recipients with cytomegalovirus infection who received maribavir in the Phase 3 SOLSTICE trial: Data at 52 weeks post-maribavir treatment initiation	22
Cost-effectiveness of tenofovir alafenamide fumarate for treatment of chronic hepatitis B: Evidence from a tertiary hospital in Vietnam	17
Abacavir safety and effectiveness in young infants with HIV in South African observational cohorts	16
Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants	16
It’s about time: The association between abacavir and cardiovascular disease	15
In-silico approach to characterize the structure and function of a hypothetical protein of Monkeypox virus exploring Chordopox-A20R domain-containing protein activity	13
RVX-208, an inducer of Apolipoprotein A-I, inhibits the particle production of hepatitis B virus through activation of cGAS-STING pathway	9
Seroprevalence, seroconversion, and mother-to-child transmission of dual and triplex infections of HIV, HBV, and HCV among Nigerian obstetric population: A national multicentre prospective cohort stud	8
Best practices for screening, testing, diagnosing, and treating patients with hepatitis D (delta) virus based on global expert review and recent guidelines	7
Dolutegravir and rilpivirine as successful initial antiretroviral therapy in a treatment-naive patient with HIV-1: A case report	7
Pharmacokinetic and mass balance characterization of [ ¹⁴ C] RAY1216, a SARS-CoV-2 M ^pro inhibitor	7
The evolution of clinical study design in heavily treatment-experienced persons with HIV: A critical review	6
A favipiravir-induced angioedema and urticaria in a COVID-19 patient	6
Computer-assisted drug discovery of potential natural inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase through a multi-phase in silico approach	6
Andrographolide suppresses SARS-CoV-2 infection by downregulating ACE2 expression: A mechanistic study	5
Progress in the quality of care for newly diagnosed people with HIV in Spain (2004–2019)	5
The diagnostic significance of the C-reactive protein (CRP) in HIV/TB coinfection: A systematic review and meta-analysis	5
Sustained viral suppression with once daily dolutegravir-containing regimen in presence of the strong inducer carbamazepine	5
Durability of multi-drug antiretroviral therapy (mega-ART) in treatment-experienced people with HIV in the ARCA database	5
Antiretroviral therapy adherence patterns, virological suppression, and emergence of drug resistance: A nested case–control study from Uganda and South Africa	4
Lipid and glucose abnormalities and associated factors among children living with HIV in Asia	4
Hepatitis C virus/Hepatitis B virus coinfection: Current prospectives	4
Antiviral potential of phenolic compounds against HSV-1: In-vitro study	4

Analysis of risk factors and prediction model construction for varicella encephalitis in children: A retrospective cohort study	4
Feminizing hormone therapy in a Canadian cohort of transgender women with and without HIV	4
Waitlist-controlled trial of an online intervention to address mental health among older people living with HIV	4
Clinical outcomes in patients with mild to moderate coronavirus disease 2019 treated with monoclonal antibody therapy versus an untreated control cohort	4
EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis B	3
Enterovirus-associated deafness and myositis in an immunocompromised patient with in vivo and in vitro eff	3
Letermovir use to treat complex cytomegalovirus reactivations in two heart transplant recipients	3
Magnolol inhibits viral replication and enhances antiviral immune responses against porcine reproductive and respiratory syndrome virus (PRRSV) in Marc-145 cells	3
Preface: Special Collection Commemorating John C. Martin	3
Inhibition of chikungunya virus replication by N-ω-Chloroacetyl-L-Ornithine in C6/36, Vero cells and human fibroblast BJ	3
Pharmacokinetic interaction between raltegravir and rifampicin in an infant with HIV exposed to active TB: a case report	3
Increased insulin resistance following switch from efavirenz to cobicistat-boosted elvitegravir	3
Understanding the effect of direct-acting antiviral therapy on weight in patients with chronic hepatitis C	3
Comparative efficacy and safety of tenofovir amibufenamide vs tenofovir alafenamide in the initial 48-week treatment of high viral load chronic hepatitis B: A single-centre retrospective study	3
Subacute thyroiditis following COVID-19 vaccination: Case presentation	3
Resistance levels to non-nucleoside reverse transcriptase inhibitors among pregnant women with recent HIV infection in Malawi	3